Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Antineoplastics

Various toxicities and lack of efficacy : 5 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tian Y, et al. Efficacy analysis of Venetoclax combined with TKI and dexamethasone-containing low-dose chemotherapy for relapsed/refractory Ph+acute B-lymphoblastic leukemia. Zhonghua Yi Xue Za Zhi 102: 745-748, No. 10, 15 Mar 2022. Available from: URL: http://doi.org/10.3760/cma.j.cn112137-20210728-01676 [Chinese; summarised from a translation] Tian Y, et al. Efficacy analysis of Venetoclax combined with TKI and dexamethasone-containing low-dose chemotherapy for relapsed/refractory Ph+acute B-lymphoblastic leukemia. Zhonghua Yi Xue Za Zhi 102: 745-748, No. 10, 15 Mar 2022. Available from: URL: http://​doi.​org/​10.​3760/​cma.​j.​cn112137-20210728-01676 [Chinese; summarised from a translation]
Metadaten
Titel
Antineoplastics
Various toxicities and lack of efficacy : 5 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41315-z

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Immune globulin

Case report

Vasopressin